What Know About Orbimed's Influence on Enliven's 130% Rally
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Which index fund performed best this year? Review top performers, volatility, and potential shifts to inform your next move.
26,831 articlesA major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
NVIDIA’s market value dips below the $5 trillion threshold as traders reassess AI demand and supply dynamics. Analyst...
As policymakers migrate from restraint to regulation, Washington signals a bipartisan push for federal AI licensing, ...
Oil traded near a multi-week low on July 10, 2026, with Brent around $76.80 per barrel. Investors and households alik...
A July 12 KBW report argues artificial intelligence will fortify the industry’s largest lenders rather than upend the...
When a trusted bookkeeper holds the keys to a company’s wire transfers, financial risk rises. This guide explains how...
TD Bank has been on investors' radars, but sustained upside hinges on three core drivers. Explore how regulatory shif...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
Wayne Peacock, former USAA CEO, joins Cotality's board as an independent director. The appointment signals a data-dri...
Apple unveiled a refreshed iPhone and iPad Air lineup with bigger storage, underscoring a broader AI push. The move a...
Bank of America reinstates Ford with a Buy rating and a $17 target, while Rivian is downgraded to Underperform with a...
OmniPact raises $50 million in a private round to accelerate its cross-chain trust layer. The funds will power a Q1 2...